《新股消息》泰林科建(06193.HK)下限定价1.3元 一手中签率仅15%
江苏PHC管桩及商品混凝土制造商泰林科建(06193.HK)公布招股结果,发售价厘定为每股1.3元,为下限定价(招股价介乎1.3至1.4元)。每手2,000股,中签率为15.01%。该股将於明日(18日)挂牌,南华金融为独家保荐人。
该股公开发售部分获超额认购40.99倍,国际配售则轻微认购不足。股份经重新分配後,公开发售之比例增至20%。
公司预计所得款项净额将约为6,370万元,当中约48.6%将用於扩充生产设施;33.7%用於提早偿还银行贷款;6.1%用於进一步提升环保系统等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.